actikerall 5 mg/g + 100 mg/g solucion cutanea
almirall hermal gmbh - fluorouracilo; salicilico acido - soluciÓn cutÁnea - 5 mg/g + 100 mg/g - fluorouracilo 5 mg; salicilico acido 100 mg - fluorouracilo, combinaciones con
uft 100 mg/224 mg capsulas duras
merck, s.l. - tegafur, uracilo - excipientes: laurilsulfato de sodio - antimetabolitos - análogos de las pirimidinas - tegafur, combinaciones con
lonsurf
les laboratoires servier - trifluridine, tipiracil clorhidrato de - neoplasias colorrectales - agentes antineoplásicos - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasmas estomacales - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
paltegafur 100mg/224mg capsula
palmagyar s.a. - capsula - por capsula - tegafur, combinaciones
lonsurf 15 mg / 6,14 mg comprimido recubierto
efa laboratorios - comprimido recubierto - trifluridina 15 mg + tipiracilo 6,14 mg comprimido
lonsurf 20 mg/8,19 mg comprimido recubierto
efa laboratorios - comprimido recubierto - trifluridina 20 mg + tipiracilo 8,19 mg comprimido
lonsurf 20 mg/ 8.19 mg comprimidos recubiertos con película
les laboratoires servier francia - cada comprimido recubierto con película contiene: trifluridina 20 mg tipiracilo 8.19 mg (equivalente a 9.420 mg de tipiracilo hidrocloruro ) - comprimidos recubiertos con pelicula - cada comprimido recubierto con película contiene: trifluridina 20 mg tipiracilo 8.19 mg (equivalente a 9.420 mg de tipiracilo hidrocloruro )
lonsurf 15 mg/ 6.14 mg comprimidos recubiertos con película
les laboratoires servier francia - cada comprimido recubierto con película contiene: trifluridina 15 mg tipiracilo de hidrocloruro 7,065 mg equivalente a tipiracilo 6,14 mg - comprimidos recubiertos con pelicula - cada comprimido recubierto con película contiene: trifluridina 15 mg tipiracilo de hidrocloruro 7,065 mg equivalente a tipiracilo 6,14 mg
suprol
laboratorio varifarma s.a. argentina - cada comprimido recubierto contiene: trifluridina 20,00 mg tipiracilo* 8,19 mg * como tipiracilo clorhidrato 9,42 mg - comprimido recubierto - trifluridina 20,00 mg tipiracilo* 8,19 mg * como tipiracilo clorhidrato 9,42 mg